BAK: a better alternative to epithelium removal in cross linking

Article

Can BAK be used in corneal cross linking?

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Subscribe Now!
Recent Videos
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Dr Richard Lindstrom, Chairman of Surface Ophthalmics and founder of Minnesota Eye Consultants, speaks about ASCRS
Related Content
A woman in a surgical mask, covering her nose and mouth, rubs her eyes. Concept image for autoimmune disease correlation to dry eye disease. Image credit: ©Prostock-studio – stock.adobe.com

Diagnosing types of dry eye in patients with autoimmune disease

Lynda Charters
April 24th 2025
Article

A series of gears with arrows pointing right in the center of each one. Concept image for five-step approach to dry eye disease. Image credit: ©Cagkan – stock.adobe.com

New trends in the diagnosis of dry eye disease: A patient-centric approach

Marc Labetoulle, MD, PhD
April 21st 2025
Article

A five-step approach to personalise and simplify treatment, leading to higher efficacy

A child under a blanket scrolls on a cell phone. Concept image for phone use, short form content, TikTok, Instagram, ocular pathologies and eye health. Image credit: ©Siniehina – stock.adobe.com

"Reel vision syndrome" and short-form videos linked to negative ocular health outcomes

Martin David Harp
April 10th 2025
Article

Ophthalmologists report that dry eye syndrome, myopia progression and other ocular pathologies have increased, especially among paediatric patient groups

A map of Europe with a digital overlay. Concept image for European EU commercialisation and CE mark. Image credit: ©garrykillian – stock.adobe.com

Canalicular gel Lacrifill (Nordic Pharma) receives CE Mark

Hattie Hayes
April 7th 2025
Article

Nordic Pharma plans to announce commercialisation details in the near future for the dry eye disease treatment

A screenshot of the United States Food and Drug Administration (FDA) web page. US FDA Complete Response Letter CRL concept. Image credit: ©Jarretera – stock.adobe.com

US FDA issues second Complete Response Letter for dry eye drug reproxalap (Aldeyra Therapeutics)

Martin David Harp
April 3rd 2025
Article

Aldeyra previously received a CRL for its initial New Drug Application for reproxalap in November 2023

A phone with the Alcon logo on it, visible against another digital background. Concept image for Alcon company acquisition of Aurion Biotech. Image credit: ©Mojahid Mottakin – stock.adobe.com

Alcon acquires majority interest in cell therapy company Aurion Biotech, provides operational updates

Martin David Harp
March 27th 2025
Article

AURN001 is Aurion Biotech's clinical-stage allogeneic cell therapy asset for corneal oedema secondary to corneal endothelial disease

© 2025 MJH Life Sciences

All rights reserved.